Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?

Adjusting blast% to cellularity did not improve prognostication. However, within IPSS-R-defined blast groups, a small subset of patients with relatively higher blast% and hypercellularity may have a worse prognosis than expected.